PALI
NASDAQ
$1.91
Palisade Bio Inc (PALI)
Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company is headquartered in Carlsbad, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $10.50 (+449.74%)
Market Cap
$340M
Free Cash Flow Yield
-3.65%
Price Chart
Valuation
Market Cap$340M
P/S11.78
P/B2.63
Profitability
EBITDA-$26M
EPS-$0.17
Financial Health
Free Cash Flow Yield-3.65%
Growth & Risk
FCF 5Y CAGR+12.00%
Sharpe Ratio1.29